Cargando…

The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials

The objective of this study was to assess whether convalescent plasma therapy could offer survival advantages for patients with novel coronavirus disease 2019 (COVID-19). An electronic search of Pubmed, Web of Science, Embase, Cochrane library and MedRxiv was performed from January 1st, 2020 to Apri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Zhenbei, Zhang, Zhijin, Ma, Haomiao, Shao, Shuai, Kang, Hanyujie, Tong, Zhaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366612/ https://www.ncbi.nlm.nih.gov/pubmed/35967398 http://dx.doi.org/10.3389/fimmu.2022.964398

Ejemplares similares

Effect of different levels of PEEP on mortality in ICU patients without acute respiratory distress syndrome: systematic review and meta-analysis with trial sequential analysis
por: Shao, Shuai, et al.
Publicado: (2021)

Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: A systematic review and meta-analysis
por: Shao, Shuai, et al.
Publicado: (2021)

Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression
por: Shao, Shuai, et al.
Publicado: (2020)

Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation: a systematic review and meta-analysis
por: Kang, Hanyujie, et al.
Publicado: (2019)

Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis
por: Jorda, Anselm, et al.
Publicado: (2022)

Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
por: Körper, Sixten, et al.
Publicado: (2022)

Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment
por: Ouyang, Jing, et al.
Publicado: (2020)

Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
por: Filippatos, Charalampos, et al.
Publicado: (2023)

Evaluation of an innovative mHealth-based integrated modality for smoking cessation in Chinese smokers: protocol for a randomized controlled trial
por: Chu, Shuilian, et al.
Publicado: (2023)

Convalescent Plasma—A Light at the End of the Tunnel: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Sarkar, Soumya, et al.
Publicado: (2021)

Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19
por: Van Damme, Karel F. A., et al.
Publicado: (2020)

Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion
por: Wirz, Oliver F., et al.
Publicado: (2021)

Editorial: Updates on convalescent plasma and monoclonal antibody therapies for infectious disease in patients with primary immunodeficiency
por: Condino-Neto, Antonio, et al.
Publicado: (2022)

Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology
por: Cognasse, Fabrice, et al.
Publicado: (2022)

Convalescent Plasma in the Treatment of Severe COVID-19: A Systematic Review and Meta-Analysis
por: ZHANG, Xuanguo, et al.
Publicado: (2020)

High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients
por: Greenbaum, Uri, et al.
Publicado: (2021)

Neutralization effect of plasma from vaccinated COVID-19 convalescents on SARS-CoV-2 Omicron variants
por: Xie, Yudi, et al.
Publicado: (2022)

Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment
por: Wu, Jian, et al.
Publicado: (2021)

Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma
por: Gilchuk, Pavlo, et al.
Publicado: (2021)

Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2
por: Taşlı, Neslihan Pakize, et al.
Publicado: (2022)

Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors
por: Vinkenoog, Marieke, et al.
Publicado: (2022)

Safety and Efficacy of Nemolizumab for Atopic Dermatitis With Pruritus: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials
por: Liang, Junqin, et al.
Publicado: (2022)

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
por: Axfors, Cathrine, et al.
Publicado: (2021)

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
por: Simonovich, Ventura A., et al.
Publicado: (2020)

Efficacy and Safety of COVID-19 Treatment Using Convalescent Plasma Transfusion: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Lee, Hyun-Jun, et al.
Publicado: (2022)

Convalescent plasma trial shows no benefit
por: Brown, Matthew
Publicado: (2020)

Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis
por: Bansal, Vikas, et al.
Publicado: (2021)

Efficacy and Safety of Convalescent Plasma for COVID-19: A Systematic Review and Meta-analysis
por: Prasad, Manya, et al.
Publicado: (2021)

Convalescent Plasma in Older Adults with COVID-19: A Systematic Review and Meta-Analysis
por: Aryana, I Gusti Putu Suka, et al.
Publicado: (2022)

A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO™)
por: Gül, Fethi, et al.
Publicado: (2022)

Mid-titer human convalescent plasma administration results in suboptimal prophylaxis against SARS-CoV-2 infection in rhesus macaques
por: Beddingfield, Brandon J., et al.
Publicado: (2023)

Association of Blood Inflammatory Biomarkers with Clinical Outcomes in Patients with AECOPD: An 8-Year Retrospective Study in Beijing
por: Shao, Shuai, et al.
Publicado: (2023)

Effects of moxibustion for COVID-19 convalescence: A protocol for systematic review and meta-analysis
por: Zhou, Yue, et al.
Publicado: (2021)

Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients
por: Millat-Martinez, Pere, et al.
Publicado: (2022)

Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery
por: Zimmerli, Aurelia, et al.
Publicado: (2021)

Challenges of Convalescent Plasma Therapy on COVID-19
por: Zhao, Qian, et al.
Publicado: (2020)

Convalescent plasma for COVID-19: a meta-analysis, trial sequential analysis, and meta-regression
por: Snow, Timothy A.C., et al.
Publicado: (2021)

Crucial Mutations of Spike Protein on SARS-CoV-2 Evolved to Variant Strains Escaping Neutralization of Convalescent Plasmas and RBD-Specific Monoclonal Antibodies
por: Ding, Chengchao, et al.
Publicado: (2021)

COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
por: Senefeld, Jonathon W., et al.
Publicado: (2023)

Convalescent plasma and all-cause mortality of COVID-19 patients: systematic review and meta-analysis
por: Mihalek, Nora, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mvlkdhbrorikege7l3uv1d5lc7